Literature DB >> 3158603

Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs.

D R Knight, D A Kirby, S F Vatner.   

Abstract

The effects of nitrendipine, 8 micrograms/kg/minute, were evaluated in six conscious dogs through measurements of arterial pressure and blood flow in the ascending aorta (cardiac output), mesenteric, renal, and iliac arteries before and after induction of chronic perinephritic hypertension. Before hypertension was induced, nitrendipine reduced mean arterial pressure 19 +/- 2.3% (from 95 +/- 3.2 mm Hg), decreased total peripheral resistance (60 +/- 2.6%), and increased cardiac output (108 +/- 10.5%). These values returned to baseline within 15 to 30 minutes. Nitrendipine caused the greatest increase in blood flow in the iliac bed (98 +/- 9.9%), an intermediate increase in the mesenteric bed (37 +/- 3.7%), and the least increase in the renal bed (7 +/- 2.2%). Two to six weeks after induction of hypertension, administration of nitrendipine elicited significant (p less than 0.01) decreases in mean arterial pressure (32 +/- 2.5% from 151 +/- 4.8 mm Hg) and total peripheral resistance (67 +/- 1.3%) compared with its administration in normotensive dogs, while the increase in cardiac output was not significantly changed (111 +/- 10.9%). These changes in arterial pressure and vascular resistances also were prolonged (i.e., hemodynamics returned to baseline after 75-90 minutes). The increase in iliac (99 +/- 16.8%) and renal (9 +/- 6.1%) blood flows after nitrendipine administration in hypertensive dogs was similar to that found in the normotensive dogs, but mesenteric blood flow doubled (84 +/- 8.4%). Thus, in conscious, hypertensive dogs, nitrendipine administration appears to markedly decrease arterial pressure and total peripheral and regional resistances, which also require more time to return to baseline, but appears to increase blood flow by a greater amount only in the mesenteric bed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158603

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats.

Authors:  Fumio Ohta; Tomo Takagi; Hiroyuki Sato; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

2.  Inhibition of smooth muscle myosin as a novel therapeutic target for hypertension.

Authors:  Xin Zhao; David Ho; Patricio Abarzúa; Sunil K Dhar; Xi Wang; Zhiheng Jia; Malar Pannirselvam; David J Morgans; Fady I Malik; Stephen F Vatner
Journal:  J Pharmacol Exp Ther       Date:  2011-07-22       Impact factor: 4.030

Review 3.  Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  K L Goa; E M Sorkin
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

4.  Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure.

Authors:  J P Longabaugh; D E Vatner; S F Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  A digital health peri-operative cognitive-behavioral intervention to prevent transition from acute to chronic postsurgical pain in adolescents undergoing spinal fusion (SurgeryPalTM): study protocol for a multisite randomized controlled trial.

Authors:  Jennifer A Rabbitts; Chuan Zhou; Rocio de la Vega; Homer Aalfs; Caitlin B Murray; Tonya M Palermo
Journal:  Trials       Date:  2021-07-30       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.